Janssen Pharmaceuticals, Inc.
CAGE Code: 78CR4
NCAGE Code: 78CR4
Status: Active
Type: Commercial Supplier
Summary
Janssen Pharmaceuticals, Inc. is an Active Commercial Supplier with the Cage Code 78CR4.
Address
920 Route 202
Raritan NJ 08869-1420
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Mcneil Lab Inc Ortho Pharmaceutical Corp Ortho-Mcneil Pharmaceutical Taft Air Inc Jordan And Pease Architects Aia Pa Design Resources Group Inc Critikon Inc Henderson Corp The Hbi Technology Llc Ufp Technologies Inc Synabridge Corporation Tab Products Of New Jersey Inc Nordevco Inc Ortho-Clinical Diagnostics, Inc N M W Products Inc Temporary Services Co Inc Science Commercial File And Storage Inc Experienced It Solutions Llc Ortho Diagnostics J And J-Jelco Laboratories
Frequently Asked Questions (FAQ) for CAGE 78CR4
- What is CAGE Code 78CR4?
- 78CR4 is the unique identifier used by NATO Organizations to reference the physical entity known as Janssen Pharmaceuticals, Inc. located at 920 Route 202, Raritan NJ 08869-1420, United States.
- Who is CAGE Code 78CR4?
- 78CR4 refers to Janssen Pharmaceuticals, Inc. located at 920 Route 202, Raritan NJ 08869-1420, United States.
- Where is CAGE Code 78CR4 Located?
- CAGE Code 78CR4 is located in Raritan, NJ, USA.
- How Many NSNs Does CAGE Code 78CR4 Supply?
- CAGE Code 78CR4 has been assigned as an approved source for 1 NSNs (National Stock Numbers and NATO Stock Numbers).
Contracting History for CAGE 78CR4 Most Recent 25 Records
- HHSO100201700018C
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- 15 Aug 2018
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $84,915,660.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- The Purpose Of This Amendment Is To Update The Scope Of Wp 6.17 Related To Covid-19 Vaccine R&D Efforts. In Addition, Option Wps 6.11 & 6.112 Have Been Eliminated From The Sow.
- 15 Mar 2021
- The Purpose Of This Amendment Is To Update The Scope Of Wp 6.17 Related To Covid-19 Vaccine R&D Efforts. In Addition, Option Wps 6.11 & 6.112 Have Been Eliminated From The Sow.
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $1,261,139,514.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- The Purpose Of This Amendment Is To Updated Sow Reflects Discussions Held By Both Parties During The In-Process Review (Ipr) On May 4, 2021, And The Resulting Executed Joc Memo Dated September 30, 2021, And Fully Executed On November 24, 2021. This
- 4 Mar 2022
- The Purpose Of This Amendment Is To Updated Sow Reflects Discussions Held By Both Parties During The In-Process Review (Ipr) On May 4, 2021, And The Resulting Executed Joc Memo Dated September 30, 2021, And Fully Executed On November 24, 2021. This
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $1,261,139,514.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- This Amendment 12 Agreement Makes Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg's Ownership Interest In 150,000 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 300,000 5X1010 Vp Va
- 11 Feb 2021
- This Amendment 12 Agreement Makes Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg's Ownership Interest In 150,000 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 300,000 5X1010 Vp Va
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $1,229,141,188.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Addition Of New Vaccine Asset For 2019 Novel Coronavirus (Covid-19)
- 27 Mar 2020
- Addition Of New Vaccine Asset For 2019 Novel Coronavirus (Covid-19)
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $689,525,867.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Realignment Of Budget Structure, Statement Of Work.
- 19 Dec 2019
- Realignment Of Budget Structure, Statement Of Work.
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $84,915,660.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Addition Of New Antiviral / Therapeutic Asset For 2019 Novel Coronavirus (Covid-19)
- 20 Mar 2020
- Addition Of New Antiviral / Therapeutic Asset For 2019 Novel Coronavirus (Covid-19)
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $233,288,786.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Janssen Influenza Portfolio And Other Emerging Pathogens Development Candidates
- 20 Sep 2022
- Janssen Influenza Portfolio And Other Emerging Pathogens Development Candidates
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $1,261,139,514.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- 16 Feb 2018
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $84,915,660.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- 7 Mar 2019
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $84,915,660.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Administrative Modification To Align Funded Amount On Agreement For Reporting Consistency On External Facing Data Reporting Websites (Beta.Sam.Gov / Fpds)
- 31 Mar 2020
- Administrative Modification To Align Funded Amount On Agreement For Reporting Consistency On External Facing Data Reporting Websites (Beta.Sam.Gov / Fpds)
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $689,525,867.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- The Purpose Of This Amendment Is To Make Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg?S Ownership Interest In 8,320 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 16,640 5X1010 Vp Vaccine
- 1 Jun 2021
- The Purpose Of This Amendment Is To Make Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg?S Ownership Interest In 8,320 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 16,640 5X1010 Vp Vaccine
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $1,261,139,514.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- This Amendment, Based On Joint Oversight Committee (Joc) Recommendation, Documented In Memo #12 Dated 16 June 2020, And In Accordance With Article Iv Of The Ota, Adds (I) A Non-Human Primate (Nhp) Within Work Package (Wp) 6.2, (Ii) Adds A Randomized,
- 13 Nov 2020
- This Amendment, Based On Joint Oversight Committee (Joc) Recommendation, Documented In Memo #12 Dated 16 June 2020, And In Accordance With Article Iv Of The Ota, Adds (I) A Non-Human Primate (Nhp) Within Work Package (Wp) 6.2, (Ii) Adds A Randomized,
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $1,229,141,188.00
- Department Of Health And Human Services (Hhs)
- HHSO100201500014C
- Igf::Ot::Igf
- 9 May 2019
- Igf::Ot::Igf
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $143,548,290.00
- Department Of Health And Human Services (Hhs)
- HHSO100201500014C
- Modification P00011 Addresses The Following: (1) Reallocate Funds From Clins 0001, 0003, 0004, 0011, 0012, And 0013 To Clin 0005. (2) Add $34,800,000 In Supplemental Funding To Cover Cost Overruns On Clin 0005. (3) Revise Articles B.2., B.3., F.
- 12 May 2020
- Modification P00011 Addresses The Following: (1) Reallocate Funds From Clins 0001, 0003, 0004, 0011, 0012, And 0013 To Clin 0005. (2) Add $34,800,000 In Supplemental Funding To Cover Cost Overruns On Clin 0005. (3) Revise Articles B.2., B.3., F.
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $178,348,290.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- The Purpose Of This Amendment Is To Make Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg?S Ownership Interest In 8,320 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 16,640 5X1010 Vp Vaccine
- 19 Jan 2022
- The Purpose Of This Amendment Is To Make Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg?S Ownership Interest In 8,320 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 16,640 5X1010 Vp Vaccine
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $1,261,139,514.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- 27 Dec 2018
- Aspr-17-03390 -- Janssen Influenza Portfolio -- Advanced Development Candidates (Other Transactional Authority)
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $84,915,660.00
- Department Of Health And Human Services (Hhs)
- HHSO100201500014C
- Igf::Ot::Igf
- 26 Jul 2018
- Igf::Ot::Igf
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $143,548,290.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- Addition Of New Asset For 2019 Novel Corona Virus (Covid), Budget Restructure To Fund New Asset From Existing Uniflu Funding, Addition Of Program Management Lead For New Asset.
- 11 Feb 2020
- Addition Of New Asset For 2019 Novel Corona Virus (Covid), Budget Restructure To Fund New Asset From Existing Uniflu Funding, Addition Of Program Management Lead For New Asset.
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $84,915,660.00
- Department Of Health And Human Services (Hhs)
- HHSO100201500014C
- All Clins Will End Effective, 9/30/2021
- 21 Oct 2021
- All Clins Will End Effective, 9/30/2021
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $178,348,290.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700018C
- The Purpose Of This Amendment Makes Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg?S Ownership Interest In 100,000 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 200,000 5X1010 Vp Vaccine Do
- 31 Mar 2021
- The Purpose Of This Amendment Makes Bilateral Changes Within The General Scope Of This Agreement To (I) Relinquish Usg?S Ownership Interest In 100,000 Vials Of Ad26.Cov2.S Vaccine Containing 2X1011 Vp / Ml (Equivalent To 200,000 5X1010 Vp Vaccine Do
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $1,261,139,514.00
- Department Of Health And Human Services (Hhs)
Supply Items Approved for CAGE 78CR4 Page 1 of 1
- NDC50458-0586-01
- RNCC: 3 | RNVC: 2 | DAC: 4